SCHEMBL7496509

SCHEMBL7496509

Fc1cccnc1-c1cccc2ccccc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 2/20 0.49
KDM4E B2RXH2 4/20 0.46
ALDH1A1 P00352 2/20 0.46
MAPT P10636 2/20 0.46
HPGD P15428 2/20 0.46
HSD17B10 Q99714 2/20 0.46
GAA P10253 1/20 0.46
NPC1 O15118 2/20 0.44
F2 P00734 1/20 0.43
F10 P00742 1/20 0.43
F7 P08709 1/20 0.43
F3 P13726 1/20 0.43
CYP3A4 P08684 1/20 0.43
GABRG2 P18507 1/20 0.43
GABRB3 P28472 1/20 0.43
GABRA5 P31644 1/20 0.43
GABRA3 P34903 1/20 0.43
TGFBR1 P36897 1/20 0.42
TP53 P04637 1/20 0.42
MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3255665 0.83 BCHE (0.53) BCHEKDM4EALDH1A1MAPTHPGD
SCHEMBL15901793 0.81 BCHE (0.57) BCHEKDM4EALDH1A1MAPTHPGD
SCHEMBL8129741 0.79 CYP1A2 (0.50) BCHEKDM4EALDH1A1MAPTHPGD
SCHEMBL28312221 0.79 ALDH1A1 (0.50) BCHEKDM4EALDH1A1MAPTHPGD
SCHEMBL6637133 0.79 CYP1A2 (0.50) BCHEKDM4EALDH1A1MAPTHPGD
SCHEMBL29730423 0.79 CYP1A2 (0.50) BCHEKDM4EALDH1A1MAPTHPGD
SCHEMBL21033797 0.79 ALDH1A1 (0.50) BCHEKDM4EALDH1A1MAPTHPGD
SCHEMBL29986041 0.77 BCHE (0.58) BCHEKDM4EALDH1A1MAPTHPGD
SCHEMBL158912 0.77 BCHE (0.58) BCHEKDM4EALDH1A1MAPTHPGD
SCHEMBL16502630 0.77 PLA2G2D (0.46) KDM4ESMN1; SMN2DHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020091116-A1 Show selectivity for factor Xa versus other proteases of coagulation or the fibrinolytic cascades MILLENNIUM PHARMACEUTICALS, INC. 2002-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020091116-A1 Show selectivity for factor Xa versus other proteases of coagulation or the fibrinolytic cascades SERPINC1, TFPI, F2 BCHE 339/4885KDM4E 3940/4885ALDH1A1 4324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.